In today's
environment of austerity, the rate of increase in federal support needed to make up for a decade of neglect, and to keep pace with the recovering economy, will be a very tough sell.
Our present
environment of austerity adds to the uphill challenge that teachers already face.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®;
austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic
environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
B.C. taxpayers can't afford these sorts
of sweetheart deals in a time
of austerity, especially when the Minister
of the
Environment admitted that the fees paid by Nestle and oil and gas companies likely wouldn't even pay the government's bill for administration related to the legal changes.
Traditional attitudes toward the natural
environment make Indians, like the Japanese, more disposed than Americans to pursue happiness modestly.15 And almost six decades after his assassination, Gandhi's traditionalist emphasis on
austerity and self - abnegation remains a powerful part
of Indian identity.
The
austerity government, with its mean - spirited and ideological rhetoric on welfare and love
of privatisation, has created the perfect
environment for Scottish independence to thrive.
«Yet despite the challenges that such an
environment creates, coupled with the savings we have had to make in the era
of austerity, I am proud that in Westminster we have continued to innovate, protect frontline services and still deliver the lowest council tax in the country.
Even the vain and flighty Effie Trinket (Elizabeth Banks) has to adapt to the
austerity of her
environment and forego her wigs and make - up.
While increasing potential for significant global macro / monetary divergence, the meteoric ascent
of political populists & populism, the ongoing debate for renewed fiscal stimulus (vs.
austerity), latent inflation potential, etc. all suggest a (far) more conducive
environment for Record's products & services, both in terms
of winning mandates and better returns.
So that IS the hypothesis; humans have already damaged the climate
environment beyond repair; unless the whole
of mankind, adopt their
austerity measures.